Effects of Two Hypocaloric Diets on Weight Loss
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators evaluated whether an energy-restricted protein diet with low glycaemic index carbohydrates and soluble fibers (LC-P-LGI) would be more effective than a conventional diet (LC-CONV) on weight-loss and related metabolic variables.
| Condition | Intervention |
|---|---|
|
Obesity |
Other: LC-P-LGI diet Other: LC-CONV |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Open Label Primary Purpose: Health Services Research |
| Official Title: | Effects of Two Hypocaloric Diets on Weight Loss and Inflammatory Markers |
| Enrollment: | 13 |
| Study Start Date: | May 2007 |
| Study Completion Date: | July 2008 |
| Primary Completion Date: | December 2007 (Final data collection date for primary outcome measure) |
-
Other: LC-P-LGI diet
The subjects (9 men and 5 post-menopausal women) were randomly allocated, in a cross-over design, to two periods of 4 weeks of an energy restricted diet of 1200 kcal as either a conventional diet (LC- CONV) or a special energy restricted diet compensated by proteins (LC-P-LGI). The two nutritional periods were separated by a wash-out interval of 8 weeks. Before the start of the study, all subjects were instructed to maintain their usual lifestyle during the experimental period.Anthropometric parameters, glucose and lipid homeostasis and inflammatory markers were evaluated before and after each dietary period.Body fat and fat-free mass distributions were measured by a dual-energy X-ray absorptiometry (DXA, GE Lunar Prodigy Corporation, Madison, WI, USA) before and after each dietary period at the fasting state.
Eligibility| Ages Eligible for Study: | 25 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- BMI 26 to 35 Kg/m2
- 25 to 60 years old
- non diabetic subjects
Exclusion Criteria:
- SGOT and SGPT >2.5x the normal
- plasma glucose more than 1.26 g/l
- hepatic or renal or cardiac failure
Contacts and Locations| France | |
| Assistant pubique-hopitaux Paris | |
| Paris, France, 75004 | |
More Information
No publications provided by Ceprodi S.A. Kot
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Dr Florence Massiera, Ceprodi S.A. Kot |
| ClinicalTrials.gov Identifier: | NCT01312740 History of Changes |
| Other Study ID Numbers: | RCB: 2007-A00329-44 |
| Study First Received: | March 9, 2011 |
| Last Updated: | March 10, 2011 |
| Health Authority: | France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis) |
Keywords provided by Ceprodi S.A. Kot:
|
obesity dietary treatment high protein diet Low glycaemic index adipocytes |
fat mass systemic inflammatory markers improvement of complications effect on weight loss |
Additional relevant MeSH terms:
|
Obesity Weight Loss Overnutrition Nutrition Disorders |
Overweight Body Weight Signs and Symptoms Body Weight Changes |
ClinicalTrials.gov processed this record on June 17, 2013